“Our results show that AMG 176 plus gilteritinib treatment was effective and well tolerated in mouse models of AML, which supports further evaluation in a clinical setting,” Chen Xiaoyue, a post-doctoral research fellow in Oncology Research, Amgen, the developer of AMG 176, and coinvestigat...
Acknowledgments Amgen Inc. sponsored this study.doi:10.1136/lupus-2020-eurolupus.176Lei ZhouHui WangTony JiangS. GarcesLaurence E. ChengR. LenzP. KaurArchives of Disease in childhoodLupus Science & Medicine
Insulet Corporation 3.1 176 条点评 查看公司 对比 製藥及生物科技 Amgen 4.0 1823 条点评 | 30 个职位 查看公司 对比 製藥及生物科技 Pfizer 4.2 6750 条点评 | 151 个职位 查看公司 对比 slide5 of 5 醫療保健產品製造 Medline Industries 3.2 3236 条点评 查看公司 对比 製藥及生物科技 Baxter 3.7 4186 条...